Leptospirosis prevalence in Chinese populations in the last two decades

Microbes and Infection

Volumn 14, Issue 4, 2012, Pages 317-323

  Zhang, Chenglin ^a,b   Wang, Huan ^a,b   Yan, Jie ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

China; Epidemiology; Leptospira; Leptospirosis

Indexed keywords

LEPTOSPIROSIS VACCINE;

AGE; BACTERIUM ISOLATION; CHINA; CLIMATE; DISEASE CLASSIFICATION; DISEASE SURVEILLANCE; GEOGRAPHY; HUMAN; INCIDENCE; LEPTOSPIRA; LEPTOSPIRA BORGPETERSENII; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; OCCUPATION; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SHORT SURVEY;

AGE FACTORS; ANIMALS; CHINA; CLIMATE; DISEASE OUTBREAKS; HUMANS; INCIDENCE; LEPTOSPIRA; LEPTOSPIROSIS; POPULATION SURVEILLANCE; PREVALENCE; SEASONS; SEX FACTORS;

ANIMALIA; APODEMUS AGRARIUS; LEPTOSPIRA; LEPTOSPIRA INTERROGANS;

EID: 84857999366     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2011.11.007     Document Type: Short Survey

References (50)

1. WHO, leptospirosis worldwide, 1999. Wkly. Epidemiol. Rec. 1999, 74:237-242.
2. Nigel L.P. Leptospirosis. Clin. Microbiol. Rev. 2001, 14:296-326.
3. WHO, Human Leptospirosis: Guidance for Diagnosis, Surveillance and Control 2003, World Health Organization, Malta.
4. Adler B., de la Pena-Moctezuma A. Leptospira and leptospirosis. Vet. Microbiol. 2010, 140:287-296.
5. Zuerner R., Haake D., Adler B., Segers R. Technological advances in the molecular biology of Leptospira. J. Mol. Microbiol. Biotechnol. 2000, 2:455-462.
6. Storck C.H., Postic D., Lamaury I., Perez J.M. Changes in epidemiology of leptospirosis in 2003-2004, a two El Nino Southern Oscillation period, Guadeloupe archipelago, French West Indies. Epidemiol. Infect. 2008, 136:1407-1415.
7. Pappas G., Cascio A. Optimal treatment of leptospirosis: queries and projections. Int. J. Antimicrob. Agents 2006, 28:491-496.
8. Victoriano A.F.B., Smythe L.D., Gloriani-Barzaga N., Cavinta L.L., Kasai T., Limpakarnjanarat K., Ong B.L., Gongal G., Hall J., Coulombe C.A., Yanagihara Y., Yoshida S., Adler B. Leptospirosis in the Asia Pacific region. BMC Infect. Dis. 2009, 9:147.
9. Bharti A.R., Nally J.E., Ricaldi J.N., Matthias M.A., Diaz M.M., Lovett M.A., Levett P.N., Gilman R.H., Willig M.R., Gotuzzo E., Vinetza D.M. Leptospirosis: a zoonotic disease of global importance. Lancet Infect. Dis. 2003, 3:757-771.
10. Vinetz J.M. Leptospirosis. Curr. Opin. Infect. Dis. 2001, 14:527-538.
11. McBride A.J.A., Athanazio D.A., Reis M.G., Ko A.I. Leptospirosis. Curr. Opin. Infect. Dis. 2005, 18:376-386.
12. Plank R., Dean D. Overview of the epidemiology, microbiology, and pathogenesis of Leptospira spp. in humans. Microbes Infect. 2000, 2:1265-1276.
13. Yan J., Dai B., Yu E. Leptospira and Leptospirosis 2006, The People's Healthy Publishing House, Beijing, (in Chinese). second ed.
14. Leptospira and Leptospirosis 1999, MediSci, Melbourne. S. Faine, B. Adler, C. Bolin, P. Perolat (Eds.).
15. Xue F., Yan J., Picardeau M. Evolution and pathogenesis of Leptospira spp.: lessons learned from the genomes. Microbes Infect. 2009, 11:328-333.
16. Slack A.T., Symonds M.L., Dohnt M.F., Smythe L.D. The epidemiology of leptospirosis and the emergence of Leptospira borgpetersenii serovar Arborea in Queensland, Australia, 1998-2004. Epidemiol. Infect. 2006, 134:1217-1225.
17. Schmid G.P., Steere A.C., Kornblatt A.N., Kaufmann A.F., Moss C.W., Johnson R.C., Hovindhougen K., Brenner D.J. Newly recognized Leptospira species (" Leptospira-inada" serovar Lyme) isolated from human-skin. J. Clin. Microbiol. 1986, 24:484-486.
18. Simpson F.G., Green K.A., Haug G.J., Brookes D.L. Leptospirosis associated with severe pulmonary haemorrhage in Far North Queensland. Med. J. Aust. 1998, 169:151-153.
19. Seijo A., Coto H., San Juan J., Videla J., Deodato B., Cernigoi B., Messina O.G., Collia O., de Bassadoni D., Schtirbu R., Olenchuk A., de Mazzonelli G.D., Parma A. Lethal leptospiral pulmonary hemorrhage: an emerging disease in Buenos Aires, Argentina. Emerg. Infect. Dis. 2002, 8:1004-1005.
20. Silva J.J.P., Dalston M.O., Carvalho J.E.M., Setubal S., Oliveira J.M.C., Pereira M.M. Clinicopathological and immunohistochemical features of the severe pulmonary form of leptospirosis. Rev. Soc. Bras. Med. Trop. 2002, 35:395-399.
21. Dolhnikoff M., Mauad T., Bethlem E.P., Carvalho C.R.R. Leptospiral pneumonias. Curr. Opin. Pulm. Med. 2007, 13:230-235.
22. Daher E., Zanetta D.M.T., Cavalcante M.B., Abdulkader R. Risk factors for death and changing patterns in leptospirosis acute renal failure. Am. J. Trop. Med. Hyg. 1999, 61:630-634.
23. Levett P.N. Leptospirosis. Clin. Microbiol. Rev. 2001, 14:296-326.
24. Levett P.N. Leptospirosis: re-emerging or re-discovered disease?. J. Med. Microbiol. 1999, 48:417-418.
25. Ashford D.A., Kaiser R.M., Spiegel R.A., Perkins B.A., Weyant R.S., Bragg S.L., Plikaytis B., Jarquin C., Reyes J.O.D., Amador J.J. Asymptomatic infection and risk factors for leptospirosis in Nicaragua. Am. J. Trop. Med. Hyg. 2000, 63:249-254.
26. Baranton G., Postic D. Trends in leptospirosis epidemiology in France. Sixty-six years of passive serological surveillance from 1920 to 2003. Int. J. Infect. Dis. 2006, 10:162-170.
27. Sehgal S.C. Epidemiological patterns of leptospirosis. Indian J. Med. Microbiol. 2006, 24:310-311.
28. Vancrevel R., Speelman P., Gravekamp C., Terpstra W.J. Leptospirosis in travellers. Clin. Infect. Dis. 1994, 19:132-134.
29. Boland M., Sayers G., Coleman T., Bergin C., Sheehan N., Creamer E., O'Connell M., Jones L., Zochowski W. A cluster of leptospirosis cases in canoeists following a competition on the River Liffey. Epidemiol. Infect. 2004, 132:195-200.
30. Emerging Infections: Microbial Threats to Health in the United States 1992, National Academy Press, Washington, DC. L. Joshua, E.S. Robert, C.O. Stanley (Eds.).
31. Lo Y.C., Kintziger K.W., Carson H.J., Patrick S.L., Turabelidze G., Stanek D., Blackmore C., Lingamfelter D., Dudley M.H., Shadomy S.V., Shieh W.J., Drew C.P., Batten B.C., Zaki S.R. Severe leptospirosis similar to pandemic (H1N1) 2009, Florida and Missouri, USA. Emerg. Infect. Dis. 2011, 17:1145-1146.
32. Pappas G., Papadimitriou P., Siozopoulou V., Christou L., Akritidis N. The globalization of leptospirosis: worldwide incidence trends. Int. J. Infect. Dis. 2008, 12:351-357.
33. Chou Y.L., Chen C.S., Liu C.C. Leptospirosis in Taiwan, 2001-2006. Emerg. Infect. Dis. 2008, 14:856-857.
34. Chiu C.H., Wang Y.C., Yang Y.S., Chang F.Y. Leptospirosis after typhoon in Taiwan. J. Med. Sci. 2009, 29:131-134.
35. Topic M.B., Habus J., Milas Z., Tosev E.C., Stritof Z., Turk N. Human leptospirosis in Croatia: current status of epidemiology and clinical characteristics. Trans. Roy. Soc. Trop. Med. Hyg. 2010, 104:202-206.
36. Levett P.N. Leptospirosis: a forgotten zoonosis?. Clin. Appl. Immunol. Rev. 2004, 4:435-448.
37. Barcellos C., Sabroza P.C. The place behind the case: leptospirosis risks and associated environmental conditions in a flood-related outbreak in Rio de Janeiro. Cad. Saude. Publica. 2001, 17(Suppl.):59-67.
38. Sarkar U., Nascimento S.F., Barbosa R., Martins R., Nuevo H., Kalafanos I., Grunstein I., Flannery B., Dias J., Riley L.W., Reis M.G., Ko A.I. Population-based case-control investigation of risk factors for leptospirosis during an urban epidemic. Am. J. Trop. Med. Hyg. 2002, 66:605-610.
39. Vijayachari P., Sugunan A.P., Sharma S., Roy S., Natarajaseenivasan K., Sehgal S.C. Leptospirosis in the Andaman Islands, India. Trans. R. Soc. Trop. Med. Hyg. 2008, 102:117-122.
40. Singh S.S., Vijayachari P., Sinha A., Sugunan A.P., Rasheed M.A., Sehgal S.C. Clinic-epidemiological study of hospitalized cases of severe leptospirosis. Indian J. Med. Res. 1999, 109:94-99.
41. Luo D.J., Xue F., Ojcius D.M., Zhao J.F., Mao Y.F., Li L.W., Lin X.A., Yan J. Protein typing of major outer membrane lipoproteins from Chinese pathogenic Leptospira spp. and characterization of their immunogenicity. Vaccine 2010, 28:243-255.
42. Sun A.H., Chen X.J., Wu S.L., Yan J. Sensitive and specific IgM-ELISA coated by LipL32/1-LipL21-OmpL1/2 fusion protein for serological diagnosis of human leptospirosis. Biomed. Environ. Sci. 2011, 24:291-299.
43. Dong H.Y., Hu Y., Xue F., Sun D., Ojcius D.M., Mao Y.F., Yan J. Characterization of the ompL1 gene of pathogenic Leptospira species in China and cross-immunogenicity of the OmpL1 protein. BMC Microbiol. 2008, 8:223.
44. Lin X.A., Chen Y., Yan J. Recombinant multiepitope protein for diagnosis of leptospirosis. Clin. Vaccine Immunol. 2008, 15:1711-1714.
45. Romero E.C., Bernardo C.C., Yasuda P.H. Human leptospirosis: a twenty-nine-year serological study in São Paulo, Brazil. Rev. Inst. Med. Trop. Sao Paulo 2003, 45:245-248.
46. Katz A.R., Buchholz A.E., Hinson K., Park S.Y., Effler P.V. Leptospirosis in Hawaii, USA, 1999-2008. Emerg. Infect. Dis. 2011, 17:221-226.
47. Jena A.B., Mohanty K.C., Devadasan N. An outbreak of leptospirosis in Orissa, India: the importance of surveillance. Trop. Med. Int. Health 2004, 9:1016-1021.
48. Koizumi N., Watanabe H. Leptospirosis vaccines: past, present, and future. J. Postgrad. Med. 2005, 53:210-214.
49. Wang Z., Jin L., Wegrzyn A. Leptospirosis vaccines. Microb. Cell. Fact. 2007, 6:39.
50. Yan Y., Chen Y., Liou W., Ding J., Chen J., Zhang J., Zhang A., Zhou W., Gao Z., Ye X., Xiao Y. An evaluation of the serological and epidemiological effects of the outer envelope vaccine to leptospira. J. Chin. Med. Assoc. 2003, 66:224-230.